| 000 | 02685 a2200757 4500 | ||
|---|---|---|---|
| 005 | 20250516030001.0 | ||
| 264 | 0 | _c20110624 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1524-4636 | ||
| 024 | 7 |
_a10.1161/ATVBAHA.111.224709 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBu, De-xiu | |
| 245 | 0 | 0 |
_aImpairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. _h[electronic resource] |
| 260 |
_bArteriosclerosis, thrombosis, and vascular biology _cMay 2011 |
||
| 300 |
_a1100-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Blocking _xpharmacology |
| 650 | 0 | 4 |
_aAntigens, Surface _xgenetics |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAtherosclerosis _xgenetics |
| 650 | 0 | 4 |
_aB7-1 Antigen _xgenetics |
| 650 | 0 | 4 | _aB7-H1 Antigen |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aCD3 Complex _xmetabolism |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aGenes, T-Cell Receptor |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHypercholesterolemia _xgenetics |
| 650 | 0 | 4 |
_aInflammation _xgenetics |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xmetabolism |
| 650 | 0 | 4 |
_aLymph Nodes _ximmunology |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aMacrophages _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xdeficiency |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aPeptides _xdeficiency |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aProgrammed Cell Death 1 Ligand 2 Protein |
| 650 | 0 | 4 | _aProgrammed Cell Death 1 Receptor |
| 650 | 0 | 4 |
_aReceptors, LDL _xdeficiency |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _xdrug effects |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
| 700 | 1 | _aTarrio, Margarite | |
| 700 | 1 | _aMaganto-Garcia, Elena | |
| 700 | 1 | _aStavrakis, George | |
| 700 | 1 | _aTajima, Goro | |
| 700 | 1 | _aLederer, James | |
| 700 | 1 | _aJarolim, Petr | |
| 700 | 1 | _aFreeman, Gordon J | |
| 700 | 1 | _aSharpe, Arlene H | |
| 700 | 1 | _aLichtman, Andrew H | |
| 773 | 0 |
_tArteriosclerosis, thrombosis, and vascular biology _gvol. 31 _gno. 5 _gp. 1100-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/ATVBAHA.111.224709 _zAvailable from publisher's website |
| 999 |
_c20665724 _d20665724 |
||